These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 38928021)

  • 1. Beyond Psychotropic: Potential Repurposing of Fluoxetine toward Cancer Therapy.
    Kadasah SF; Alqahtani AMS; Alkhammash A; Radwan MO
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells.
    Zhou T; Duan J; Wang Y; Chen X; Zhou G; Wang R; Fu L; Xu F
    Tumour Biol; 2012 Oct; 33(5):1299-306. PubMed ID: 22549660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells.
    Tzadok S; Beery E; Israeli M; Uziel O; Lahav M; Fenig E; Gil-Ad I; Weizman A; Nordenberg J
    Int J Oncol; 2010 Oct; 37(4):1043-51. PubMed ID: 20811727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A current perspective on the oncopreventive and oncolytic properties of selective serotonin reuptake inhibitors.
    Radin DP; Patel P
    Biomed Pharmacother; 2017 Mar; 87():636-639. PubMed ID: 28088112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vitro evaluation of microparticles of fluoxetine in galactomannan against biofilms of S. aureus methicilin resistant.
    Josino MAA; Rocha da Silva C; de Andrade Neto JB; Barroso FDD; Juvêncio da Silva L; Cavalcanti BC; de Moraes MO; Brito DHA; Ricardo NMPS; Júnior HVN
    Carbohydr Polym; 2021 Jan; 252():117184. PubMed ID: 33183631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enantiomers: a new problem in pharmacotherapy of depression?].
    Grodner B; Sitkiewicz D
    Psychiatr Pol; 2013; 47(3):511-8. PubMed ID: 23885544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
    Sproule BA; Naranjo CA; Brenmer KE; Hassan PC
    Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond "Psychotropic": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's Disease, and Cancer.
    Lenze EJ; Reiersen AM; Zorumski CF; Santosh PJ
    J Clin Psychiatry; 2023 Mar; 84(3):. PubMed ID: 36946597
    [No Abstract]   [Full Text] [Related]  

  • 10. Apoptotic effect of fluoxetine through the endoplasmic reticulum stress pathway in the human gastric cancer cell line AGS.
    Khin PP; Po WW; Thein W; Sohn UD
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):537-549. PubMed ID: 31707450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
    Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic Properties of Ampakines
    Radin DP; Purcell R; Lippa AS
    Anticancer Res; 2018 Jan; 38(1):265-269. PubMed ID: 29277782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal fluoxetine has long-lasting, differential effects on respiratory control in male and female rats.
    Biancardi V; Patrone LGA; Vicente MC; Marques DA; Bícego KC; Funk GD; Gargaglioni LH
    J Appl Physiol (1985); 2022 Aug; 133(2):371-389. PubMed ID: 35708704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
    Pashaei Y
    J Clin Neurosci; 2021 Jun; 88():163-172. PubMed ID: 33992179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acid deficiency does not alter the effects of chronic fluoxetine treatment on central serotonin turnover or behavior in the forced swim test in female rats.
    McNamara RK; Able JA; Liu Y; Jandacek R; Rider T; Tso P; Lipton JW
    Pharmacol Biochem Behav; 2013 Dec; 114-115():1-8. PubMed ID: 24090922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Activity Relationship Analysis of Fluoxetine for Suppression of Inflammatory Cytokine Production.
    Takenaka Y; Tanaka R; Kitabatake K; Uchiumi F; Aoki S; Kuramochi K; Tsukimoto M
    Biol Pharm Bull; 2024; 47(5):946-954. PubMed ID: 38735732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats.
    Kannen V; Marini T; Turatti A; Carvalho MC; Brandão ML; Jabor VA; Bonato PS; Ferreira FR; Zanette DL; Silva WA; Garcia SB
    Toxicol Lett; 2011 Jul; 204(2-3):134-40. PubMed ID: 21554931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled, double-blind study on the effects of SZL on patients with mild to moderate depressive disorder with comparison to fluoxetine.
    Hu Y; Wang Y; Chen C; Yang W; Zhu W; Wang Y; Liu P
    J Ethnopharmacol; 2021 Dec; 281():114549. PubMed ID: 34438029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine versus other types of pharmacotherapy for depression.
    Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.